Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

908 Devices Inc (NQ: MASS )

5.290 -0.100 (-1.86%)
Streaming Delayed Price Updated: 11:30 AM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about 908 Devices Inc

< Previous 1 2 3 Next >
908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors
From 908 Devices Inc.
Via Business Wire
908 Devices Enhances XplorIR Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and Vapors
From 908 Devices Inc.
Via Business Wire
908 Devices to Participate in Upcoming Investor Conferences
From 908 Devices Inc.
Via Business Wire
908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering
From 908 Devices Inc.
Via Business Wire
908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024
From 908 Devices Inc.
Via Business Wire
908 Devices Trace Chemical Identification Technology Adopted by European Agencies
From 908 Devices Inc.
Via Business Wire
908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform
From 908 Devices Inc.
Via Business Wire
908 Devices to Participate in Upcoming Investor Conferences
From 908 Devices Inc.
Via Business Wire
908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024
From 908 Devices Inc.
Via Business Wire
908 Devices Announces MX908 Integration Capabilities
From 908 Devices Inc.
Via Business Wire
908 Devices Reports Third Quarter 2023 Financial Results and Narrows 2023 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System
From 908 Devices Inc.
Via Business Wire
908 Devices to Participate in Upcoming Investor Conferences
From 908 Devices Inc.
Via Business Wire
908 Devices Awarded $10.4M Order from the United States Air Force for its Handheld MX908 Device
From 908 Devices Inc.
Via Business Wire
908 Devices to Report Third Quarter Financial Results on November 7, 2023
From 908 Devices Inc.
Via Business Wire
908 Devices Enters Initial Production Phase of US Department of Defense Aerosol and Vapor Chemical Agent Detector Program
From 908 Devices Inc.
Via Business Wire
908 Devices Launches MAVERICK for Real-Time In-Line Monitoring of Multiple Bioprocess Parameters
From 908 Devices Inc.
Via Business Wire
908 Devices to Participate in the Gilmartin Group Emerging Growth Company Showcase
From 908 Devices Inc.
Via Business Wire
908 Devices Reports Second Quarter 2023 Financial Results and Updates 2023 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
908 Devices Partners with Tennessee State and Local Agencies in the Fight Against Drug Trafficking Through a New Pilot Program
From 908 Devices Inc.
Via Business Wire
908 Devices Launches Remote and Continuous Area Monitoring for Aerosol and Vapor Detection
From 908 Devices Inc.
Via Business Wire
908 Devices to Report Second Quarter Financial Results on August 8, 2023
From 908 Devices Inc.
Via Business Wire
908 Devices Features its High-Speed, High-Resolution Separations Technology at the 71st ASMS Conference
From 908 Devices Inc
Via Business Wire
908 Devices to Participate in the William Blair 43rd Annual Growth Stock Conference
From 908 Devices Inc.
Via Business Wire
908 Devices Reports First Quarter 2023 Financial Results and Reiterates 2023 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
908 Devices Launches Data Analysis Visualization Tool for REBEL At-line Cell Culture Media Analyzer
From 908 Devices Inc
Via Business Wire
Resilience Demonstrates Lower Cost of Perfusion Bioreactor Process Using 908 Devices’ REBEL At-line Analyzer
From 908 Devices Inc.
Via Business Wire
908 Devices to Report First Quarter Financial Results on May 9, 2023
From 908 Devices Inc.
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.